D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
1326
DELISTED
Veren
VRN
| $11M | 0.01% |
2,398,115
-1,720,400
| -42% | -$6.36M |
|
1327
Wintrust Financial
WTFC
$10.7B
| $11M | 0.01% |
137,134
-25,402
| -16% | -$1.88M |
|
1328
Yum! Brands
YUM
$40.7B
| $11M | 0.01% |
+90,041
| New | +$11.4M |
|
|
JHG
1329
DELISTED
Janus Henderson
JHG
| $11M | 0.01% |
265,740
-482,555
| -64% | -$20.1M |
|
1330
Sanmina
SANM
$11.2B
| $11M | 0.01% |
284,959
-14,097
| -5% | -$541K |
|
|
TGI
1331
DELISTED
Triumph Group
TGI
| $11M | 0.01% |
589,359
+56,195
| +11% | +$1.05M |
|
1332
Houlihan Lokey
HLI
$9.75B
| $10.9M | 0.01% |
118,724
-53,878
| -31% | -$4.72M |
|
|
MNTV
1333
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $10.9M | 0.01% |
555,136
-127,922
| -19% | -$2.6M |
|
1334
PUT
Clorox
CLX
$11.8B
| $10.9M | 0.01% |
65,600
+10,500
| +19% | +$1.81M |
|
|
TBI
1335
Trueblue
TBI
$237M
| $10.9M | 0.01% |
400,727
-13,960
| -3% | -$373K |
|
1336
CALL
Live Nation Entertainment
LYV
$41.7B
| $10.8M | 0.01% |
118,700
-69,300
| -37% | -$5.84M |
|
1337
Criteo
CRTO
$1.05B
| $10.8M | 0.01% |
294,921
-59,677
| -17% | -$2.3M |
|
1338
Altimmune
ALT
$576M
| $10.8M | 0.01% |
955,438
+127,682
| +15% | +$1.55M |
|
1339
Extreme Networks
EXTR
$3.92B
| $10.8M | 0.01% |
1,094,509
-313,297
| -22% | -$3.31M |
|
|
1340
CALL
Clorox
CLX
$11.8B
| $10.8M | 0.01% |
65,000
+14,800
| +29% | +$2.55M |
|
|
KIII
1341
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $10.8M | 0.01% |
1,104,428
+979,428
| +784% | +$9.46M |
|
|
MTOR
1342
DELISTED
MERITOR, Inc.
MTOR
| $10.7M | 0.01% |
503,488
+205,551
| +69% | +$4.79M |
|
|
HZON
1343
DELISTED
Horizon Acquisition Corporation II
HZON
| $10.7M | 0.01% |
1,093,226
+66,532
| +6% | +$649K |
|
1344
CALL
C.H. Robinson
CHRW
$20.6B
| $10.7M | 0.01% |
122,900
+29,900
| +32% | +$2.7M |
|
|
VSTO
1345
DELISTED
Vista Outdoor Inc.
VSTO
| $10.7M | 0.01% |
264,506
+135,824
| +106% | +$5.6M |
|
|
RAM
1346
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
| $10.6M | 0.01% |
+1,067,000
| New | +$10.5M |
|
|
NVO
1347
Novo Nordisk
NVO
$220B
| $10.6M | 0.01% |
221,678
-55,720
| -20% | -$2.69M |
|
1348
System1
SST
$15.7M
| $10.6M | 0.01% |
107,361
| – | – |
|
1349
GeneDx Holdings
WGS
$1.8B
| $10.6M | 0.01% |
42,472
+6,061
| +17% | +$2.08M |
|
1350
Blackrock
BLK
$165B
| $10.6M | 0.01% |
12,648
+11,603
| +1,110% | +$10.4M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.